NLA GUIDELINES Bundle (free trial)

Dyslipidemia-II NLA

Official NLA Dyslipidemia Guidelines Appsbrought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512431

Contents of this Issue

Navigation

Page 19 of 37

20 Table 8. International Diabetes Federation's Definition of the At Risk Group and Metabolic Syndrome in Children and Adolescents Age group (years) Obesity (WC) Triglycerides HDL-C Blood pressure Glucose 6 –<10 a ≥90th percentile >1.7 mmol/L (≥150 mg/dL) <1.03 mmol/L (<40 mg/dL) Systolic BP >130 or diastolic BP >85 mm Hg FPG ≥ 5.6 mmol/L (100 mg/dL) b or known T2DM 10–<16 ≥90th percentile or adult cut-off if lower 16+ (Adult criteria) WC ≥94 cm for Europoid males and >80 cm for Europid females, with ethnic- specific values for other groups c ) >1.7 mmol/L (≥150 mg/dL) or specific treatment for high triglycerides <1.03 mmol/L (<40 mg/dL) in males and <1.29 mmol/L (<50 mg/dL) in females or specific treatment for low HDL Systolic BP ≥130 or diastolic BP >85 mm Hg or treatment of previously diagnosed hypertension FPG ≥ 5.6 mmol/L (100 mg/dL) b or known T2DM a Metabolic syndrome cannot be diagnosed, but further measurements should be made if there is a family history of metabolic syndrome, T2DM, dyslipidemia, cardiovascular disease. hypertension and/or obesity. b For clinical purposes, but not for diagnosing the metabolic syndrome, if FPG 5.6–6.9 mmol/L (100–125 mg/dL) and not known to have diabetes, an oral glucose tolerance test should be performed. c For those of South and South-East Asian, Japanese, and ethnic South and Central American origin, the cutoffs should be ≥90 cm for men and ≥80 cm for women. e IDF Consensus group recognize that there are ethnic, gender and age differences, but research is still needed on outcomes to establish risk. Diagnosing the metabolic syndrome requires the presence of central obesity plus any two of the other four factors. Taken from: Zimmet P, et al.; IDF Consensus Group. Pediatr Diabetes. 2007;8:299-306.284. Permission to reprint was obtained. Children and Adolescents

Articles in this issue

Archives of this issue

view archives of NLA GUIDELINES Bundle (free trial) - Dyslipidemia-II NLA